Human Telomerase Reverse Transcriptase Gene Promoter Mutation in Serum of Patients with Hepatocellular Carcinoma

Author:

Ako Soichiro,Nouso KazuhiroORCID,Kinugasa Hideaki,Matsushita Hiroshi,Terasawa Hiroyuki,Adachi Takuya,Wada Nozomu,Takeuchi Yasuto,Mandai Mari,Onishi Hideki,Ikeda Fusao,Shiraha Hidenori,Takaki Akinobu,Fujioka Shinichi,Mimura Tetsushige,Okada Hiroyuki

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference25 articles.

1. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019 Apr;144(8):1941–53.

2. Nouso K, Kobayashi Y, Nakamura S, Kobayashi S, Toshimori J, Kuwaki K, et al. Evolution of prognostic factors in hepatocellular carcinoma in Japan. Aliment Pharmacol Ther. 2010 Feb;31(3):407–14.

3. Kudo M, Izumi N, Sakamoto M, Matsuyama Y, Ichida T, Nakashima O, et al. Survival analysis over 28 Years of 173,378 patients with hepatocellular carcinoma in Japan. Liver Cancer. 2016 Jul;5(3):190–7.

4. de Lange T. Protection of mammalian telomeres. Oncogene. 2002 Jan;21(4):532–40.

5. Blasco MA. Telomere length, stem cells and aging. Nat Chem Biol. 2007 Oct;3(10):640–9.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3